Life Sciences Ontario Announces Recipients of 2018 LSO Awards

TORONTO--(BUSINESS WIRE)-- LSO today announced the recipients of its 2018 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards Dinner at Toronto’s Liberty Grand, February 28, 2018.

The 2018 awardees are as follows:

  • Lifetime Achievement Award: Ilse Treurnicht, Former CEO, MaRS Discovery District

  • Community Service Award: George Mallay, Past General Manager, Sarnia-Lambton Economic Partnership

  • Volunteer Award: Shanna Brisebois, Manager, Health Policy and Stakeholder Relations, Novartis Pharmaceuticals Canada Inc.

  • Life Science Company of the Year: Fusion Pharmaceuticals Inc.

The LSO Awards are an important part of the organization’s mandate to advocate for Ontario’s life sciences sector, by celebrating the individuals and companies behind its success.

“This year’s LSO Award recipients represent an outstanding group of Ontario life sciences innovators who have made an enormous impact on our sector,” says LSO President and CEO Jason Field. “Ontario’s life sciences sector holds the key to our economic and social prosperity – and it is fueled by the contributions of talented and hardworking individuals.”


Ilse Treurnicht, Former CEO, MaRS Discovery District

Lifetime Achievement Award

For the past 12 years, Ilse Treurnicht has overseen the development of the MaRS Centre, an innovation hub located in the heart of Toronto’s Discovery District, as well as the launch and growth of MaRS’ broad suite of programs and partnerships. Today, the 1.5-million-sq.-ft. facility offers specialized infrastructure to leading research groups, startups and young scaling firms, multinational businesses and investors – drawing 6,000 people from 150+ organizations to work there every day.

MaRS supports innovators and entrepreneurs building high-impact growth businesses, providing connections to critical talent, capital, and customer networks. In addition, MaRS works with partners to accelerate the adoption and diffusion of innovation in regulated sectors, with a special focus on modernizing procurement, liberating data, and developing outcomes-based funding models in the health sector.

Ilse joined MaRS in 2005 from her role as CEO of Primaxis Technology Ventures, a seed-stage venture fund. She has been a res